Isophane Protamine Recombinant Human Insulin(Novo Nordisk)

精蛋白重组人胰岛素（诺和诺德）

Report date: 2022/01/27 13:31:47

Base Information

Drug NameIsophane Protamine Recombinant Human Insulin(Novo Nordisk)
Drug Alias Name低精蛋白锌人胰岛素诺和灵N
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2016/06/16
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk (China)Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk (China)Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A